BioSpace News Archive

The U.S. Senate and House of Representatives on Thursday passed legislation strongly supported by the Emergency Nurses Association which provides healthcare workers with critical training for identifying and treating victims of human trafficking.

ORHub, Inc. (OTC: ORHB) (the “Company” or “ORHub”), today announces that key initiatives led by the Centers for Medicare and Medicaid Services (CMS) such as Promoting Interoperability will serve as a potential growth engine for the market adoption of Surgical Spotlight™.

OTC Markets Group Inc.today announced Ellex Medical Lasers Ltd. has qualified to trade on the OTCQX® Best Market. Ellex Medical Lasers Ltd. upgraded to OTCQX from the Pink® market.

Rocket Pharmaceuticals, Inc. today announces that the Company has been selected for addition to the NASDAQ Biotechnology Index®

Exemplar Genetics, a subsidiary of Intrexon Corporation (NASDAQ: XON) and market leader in the development of genetically engineered miniswine as models of human disease, and Mayo Clinic have launched a joint venture focused on the development of a high quality source of human liver cells or hepatocytes (HHCs).

Novocure (NASDAQ: NVCR) will participate in the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 9, 2019, in San Francisco.

Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq: NBI).

Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy, today announced that Usman “Oz” Azam, MD, President and Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biopharmaceutical Group active in 136 countries worldwide, today announced that Berlin Chemie AG, the German company of the Menarini Group, has been granted exclusive licensing rights to commercialize Pracinostat worldwide (excluding US, Canada, Japan and South America).

OncoSec Medical Inc. (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, announced today that Joon Kim, J.D., a partner at Lee & Ko, has been appointed to OncoSec’s Board of Directors.